Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk

  • Tiva T. Vancleave
  • , Jason H. Moore
  • , Marnita L. Benford
  • , Guy N. Brock
  • , Ted Kalbfleisch
  • , Richard N. Baumgartner
  • , James W. Lillard
  • , Rick A. Kittles
  • , La Creis R. Kidd

Producción científica: Articlerevisión exhaustiva

35 Citas (Scopus)

Resumen

BACKGROUND. Prostate cancer (PCa) incidence and mortality are disproportionately high among African-American (AA) men. Its detection and perhaps its disparities could be improved through the identification of genetic susceptibility biomarkers within essential biological pathways. Interactions among highly variant genes, central to angiogenesis, may modulate susceptibility for prostate cancer, as previous demonstrated. This study evaluates the interplay among three highly variant genes (i.e., IL-10, TGFβR-1, VEGF), their receptors and their influence on PCa within a case-control study consisting of an under-served population. METHODS. This study evaluated single gene and joint modifying effects on PCa risk in a case-control study comprised of 859 AA men (193 cases and 666 controls) using TaqMan qPCR. Interaction among polymorphic IL-10, TGFβR-1 and VEGF was analyzed using conventional logistic regression analysis (LR) models, multi-dimensionality reduction (MDR) and interaction entropy graphs. Symbolic modeling allowed validation of gene-gene interaction findings identified by MDR. RESULTS. No significant single gene effects were demonstrated in relation to PCa risk. However, carriers of the VEGF 2482T allele had a threefold increase in the risk of developing aggressive PCa. The presence of VEGF 2482T combined with VEGFR IVS6+54 loci were highly significant for the risk of PCa based on MDR and symbolic modeling analyses. These findings were substantiated by 1,000-fold cross validation permutation testing (P=0.04), respectively.

Idioma originalEnglish
Páginas (desde-hasta)341-352
Número de páginas12
PublicaciónProstate
Volumen70
N.º4
DOI
EstadoPublished - mar 1 2010

Financiación

FinanciadoresNúmero del financiador
National Childhood Cancer Registry – National Cancer InstituteU54CA118638

    ODS de las Naciones Unidas

    Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

    1. Good health and well being
      Good health and well being

    ASJC Scopus subject areas

    • Oncology
    • Urology

    Huella

    Profundice en los temas de investigación de 'Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk'. En conjunto forman una huella única.

    Citar esto